Sanofi SA
SNYView Detailed Chart
51.980USD
-2.640-4.83%
Close 04/04, 16:00（ET）Quotes delayed by 15 min
130.32BMarket Cap
21.53P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-4.83%
5 Days
-6.89%
1 Month
-12.52%
6 Months
-6.29%
Year to Date
+7.77%
1 Year
+10.01%
View Detailed Chart
Agency Rating
Analyst Rating
Based on
7
analysts
BUY
Current Rating
63.122
Target Price
21.43%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
150
Total
5
Median
7
Average
Company name
Ratings
Analysts
Sanofi SA
SNY
7
Biogen Inc
BIIB
37
Alnylam Pharmaceuticals Inc
ALNY
33
Amgen Inc
AMGN
33
Gilead Sciences Inc
GILD
30
BioMarin Pharmaceutical Inc
BMRN
29
1
2
3
...
30
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Sell
Indicators
Indicators
Value
Direction
MACD(12,26,9)
-1.207
Neutral
RSI(14)
33.163
Neutral
STOCH(KDJ)(9,3,3)
11.896
Oversold
ATR(14)
1.272
High Vlolatility
CCI(14)
-157.592
Sell
Williams %R
95.488
Oversold
TRIX(12,20)
-0.131
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Indicators
Value
Direction
MA5
54.020
Sell
MA10
54.670
Sell
MA20
56.465
Sell
MA50
55.318
Sell
MA100
52.009
Sell
MA200
52.786
Sell
News
More news coming soon, stay tuned...
Company
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.
Company codeSNY
CompanySanofi SA
CEOMr. Paul Hudson, Ph.D.
Websitehttps://www.sanofi.com/
